🩺 Clinical factors predict 3-month exercise limits
🩺 Clinical factors predict 3-month exercise limits
A retrospective cohort study of 590 patients aged 75 or younger after cardiovascular surgery found that discharge-time clinical factors could predict reduced exercise capacity at 3 months; 139 patients (23.6%) had reduced exercise tolerance on follow-up cardiopulmonary exercise testing. The single-center study suggests routine clinical data can support smarter postoperative risk stratification and earlier targeting of rehabilitation in patients with heart disease.
Why It Matters To Your Practice
Functional recovery is a patient-centered outcome, but clinicians often lack a practical way at discharge to identify who will struggle with exercise tolerance after cardiovascular surgery.
A model based on readily available clinical parameters could help flag higher-risk patients before symptoms or poor recovery become fully apparent.
Clinical Implications
Consider discharge data as more than administrative information: it may support prediction of which postoperative patients will have limited peak oxygen uptake at 3 months.
Patients identified as higher risk may benefit from earlier referral to cardiac rehabilitation, closer follow-up, and more individualized recovery planning.
Because the study was retrospective and single-center, any AI-enabled tool should be validated locally before it influences care pathways.
Insights
The study included patients undergoing cardiovascular surgery between April 2015 and January 2025 at a single cardiac center.
The outcome was reduced exercise tolerance at 3 months, defined by peak oxygen uptake on cardiopulmonary exercise testing.
The focus on discharge-available variables makes the approach more realistic for workflow integration than models requiring specialized testing after discharge.
The Bottom Line
AI built from routine clinical factors may help clinicians predict 3-month exercise limitations after cardiovascular surgery and target rehabilitation sooner.
For practice, the near-term value is risk stratification, not replacement of clinical judgment.